Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food
- 1 August 1999
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (8) , 932-942
- https://doi.org/10.1592/phco.19.11.932.31568
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adultsAIDS, 1998
- Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected PatientsClinical Drug Investigation, 1993
- From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adultsJAMA, 1993
- The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infectionAIDS, 1992
- Pharmacokinetics of Stavudine in Patients with AIDS or AIDS-Related ComplexThe Journal of Infectious Diseases, 1992
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) InfectionAnnals of Internal Medicine, 1990
- Safety and tolerance of dideoxycytidine as a single agentThe American Journal of Medicine, 1990
- Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related DisordersThe Journal of Clinical Pharmacology, 1988
- Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosisThe American Journal of Medicine, 1988